Clinical Trial

FITMI - First In Treating Male Infertility

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This RCT aims to assess whether treatment with Denosumab can improve semen quality in infertile men selected by serum AMH as a positive predictive biomarker.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-01-14; most recent amendment 2024-11-13.
Status change: Recruiting → Active, Not Recruiting 2024-11-13
Trial Details
NCT Number NCT05212337
Lead Sponsor Martin Blomberg Jensen
Conditions Infertility, Male
Enrollment 180 participants
Start Date 2022-01-01
Primary Completion 2024-10-22 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-15